Adult diagnoses (age 15 through 124)

Adult diagnoses (age 15 through 124). — See additional coding rules

T47.8X6D Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
T47.8X6S Underdosing of other agents primarily affecting gastrointestinal system, sequela
T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T47.95XD Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T47.96XA Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T47.96XD Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T47.96XS Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela
T48.0X5A Adverse effect of oxytocic drugs, initial encounter
T48.0X5D Adverse effect of oxytocic drugs, subsequent encounter
T48.0X5S Adverse effect of oxytocic drugs, sequela
T48.0X6A Underdosing of oxytocic drugs, initial encounter
T48.0X6D Underdosing of oxytocic drugs, subsequent encounter
T48.0X6S Underdosing of oxytocic drugs, sequela
T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.1X5D Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T48.1X5S Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48.1X6A Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.1X6D Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T48.1X6S Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
T48.205D Adverse effect of unspecified drugs acting on muscles, subsequent encounter
T48.205S Adverse effect of unspecified drugs acting on muscles, sequela
T48.206A Underdosing of unspecified drugs acting on muscles, initial encounter
T48.206D Underdosing of unspecified drugs acting on muscles, subsequent encounter
T48.206S Underdosing of unspecified drugs acting on muscles, sequela
T48.295A Adverse effect of other drugs acting on muscles, initial encounter
T48.295D Adverse effect of other drugs acting on muscles, subsequent encounter
T48.295S Adverse effect of other drugs acting on muscles, sequela
T48.296A Underdosing of other drugs acting on muscles, initial encounter
T48.296D Underdosing of other drugs acting on muscles, subsequent encounter
T48.296S Underdosing of other drugs acting on muscles, sequela
T48.3X5A Adverse effect of antitussives, initial encounter
T48.3X5D Adverse effect of antitussives, subsequent encounter
T48.3X5S Adverse effect of antitussives, sequela
T48.3X6A Underdosing of antitussives, initial encounter
T48.3X6D Underdosing of antitussives, subsequent encounter
T48.3X6S Underdosing of antitussives, sequela
T48.4X5A Adverse effect of expectorants, initial encounter
T48.4X5D Adverse effect of expectorants, subsequent encounter
T48.4X5S Adverse effect of expectorants, sequela
T48.4X6A Underdosing of expectorants, initial encounter
T48.4X6D Underdosing of expectorants, subsequent encounter
T48.4X6S Underdosing of expectorants, sequela
T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
T48.5X5D Adverse effect of other anti-common-cold drugs, subsequent encounter
T48.5X5S Adverse effect of other anti-common-cold drugs, sequela
T48.5X6A Underdosing of other anti-common-cold drugs, initial encounter
T48.5X6D Underdosing of other anti-common-cold drugs, subsequent encounter
T48.5X6S Underdosing of other anti-common-cold drugs, sequela
T48.6X5A Adverse effect of antiasthmatics, initial encounter
T48.6X5D Adverse effect of antiasthmatics, subsequent encounter
T48.6X5S Adverse effect of antiasthmatics, sequela
T48.6X6A Underdosing of antiasthmatics, initial encounter
T48.6X6D Underdosing of antiasthmatics, subsequent encounter
T48.6X6S Underdosing of antiasthmatics, sequela
T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48.905D Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
T48.905S Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
T48.906A Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter
T48.906D Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
T48.906S Underdosing of unspecified agents primarily acting on the respiratory system, sequela
T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
T48.995D Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
T48.995S Adverse effect of other agents primarily acting on the respiratory system, sequela
T48.996A Underdosing of other agents primarily acting on the respiratory system, initial encounter
T48.996D Underdosing of other agents primarily acting on the respiratory system, subsequent encounter
T48.996S Underdosing of other agents primarily acting on the respiratory system, sequela
T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.0X5D Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.0X6A Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.0X6D Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T49.0X6S Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.1X5A Adverse effect of antipruritics, initial encounter
T49.1X5D Adverse effect of antipruritics, subsequent encounter
T49.1X5S Adverse effect of antipruritics, sequela
T49.1X6A Underdosing of antipruritics, initial encounter
T49.1X6D Underdosing of antipruritics, subsequent encounter
T49.1X6S Underdosing of antipruritics, sequela
T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
T49.2X5D Adverse effect of local astringents and local detergents, subsequent encounter
T49.2X5S Adverse effect of local astringents and local detergents, sequela
T49.2X6A Underdosing of local astringents and local detergents, initial encounter
T49.2X6D Underdosing of local astringents and local detergents, subsequent encounter
T49.2X6S Underdosing of local astringents and local detergents, sequela
T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
T49.3X5D Adverse effect of emollients, demulcents and protectants, subsequent encounter
T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
T49.3X6A Underdosing of emollients, demulcents and protectants, initial encounter
T49.3X6D Underdosing of emollients, demulcents and protectants, subsequent encounter
T49.3X6S Underdosing of emollients, demulcents and protectants, sequela
T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.4X5D Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.4X6A Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.4X6D Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T49.4X6S Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
T49.5X5D Adverse effect of ophthalmological drugs and preparations, subsequent encounter